GNW Heads Into Earnings with Options Traders Turning Bullish
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Genworth Financial heads into its May 20 earnings date with a notable divergence: options traders have shifted decisively toward calls while short sellers sit at their lowest positioning in months.
The clearest signal is in options. The put/call ratio has dropped to 0.19 — well below its 20-day average of 0.24 and more than 1.3 standard deviations beneath it. That makes the current reading one of the most call-skewed in the past year, with the 52-week low at 0.10 and the high at 0.44. The directional shift is a sharp reversal from March, when PCR ran near 0.40. Options traders are leaning bullish, not hedging for downside.
Short interest tells a more muted story. At 1.8% of the free float, positioning is modest — and bears have been retreating. SI fell roughly 11% over the past month, from a peak of around 8.2 million shares in early April to 7.25 million now. That April spike reversed quickly after mid-month, with shorts cutting exposure steadily through late April and into May. The borrow market reflects the same ease: cost to borrow runs at just 0.46%, and while that's up 43% over the past month, the absolute level remains negligible. Availability is loose — there is no squeeze pressure here, and the lending market shows no stress signal worth trading on.
Keefe, Bruyette & Woods — the only active coverage on the name — reinstated its Outperform rating in late March with a $10.50 target, implying roughly 18% upside to the current price of $8.87. Ryan Krueger has steadily ratcheted his target higher over the past year, from $8.00 last April through $9.00, $9.50, $10.00, and now $10.50. That consistent upward revision reflects improving confidence in the Enact mortgage insurance segment, which the bull case points to as a structural grower: 17% market share, 2–3% annual in-force growth, and ROEs running 11–13%. The bear case centres on legal tail risk, specifically the $850 million AXA mis-selling liability, which clouds the holding company's capital return story even as leverage has been cut sharply and buybacks have topped $590 million since 2022. The short score of 30.8 sits well into the lower half of the universe, consistent with this being a low-conviction short at current levels.
Institutional ownership is stable and concentrated. BlackRock holds 15.1% and added nearly 840,000 shares in its most recent filing. Vanguard and Dimensional hold a further 18% combined. Thomas McInerney — the company's CEO — holds 1.4% and added 361,000 shares as recently as early March, a sign of continued alignment with shareholders even if the overall insider picture is mixed (the CFO and a divisional CEO both made small sales on February 26 alongside routine award grants).
Peer performance this week leaned negative across the insurance complex, with CNA off 8.6%, L down 5.5%, and SIGI falling 4%. Against that backdrop, GNW's 1.6% weekly decline looks relatively contained. CNO edged up 2.1%, the only peer in the green.
With earnings confirmed for May 20, the setup heading into the print is one of low short pressure, call-skewed options, and a sole analyst firmly in the bull camp — the next conversation will likely centre on Enact's in-force trends and any update on the AXA litigation timeline.
Stocks in this article
See the live data behind this article on ORTEX.
Open GNW on ORTEX →How this article was generated
- Generated
- 6 May 2026, 20:03
- Data as of
- 6 May 2026, 20:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signals
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.